Integration of the 5G-based Remote Healthcare System in Critical Care
NCT ID: NCT06485518
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220 participants
OBSERVATIONAL
2022-07-01
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
NCT06652750
Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring
NCT06833801
Augmented Reality Enhanced Surgery: Use of Holographic Technology in Cranial and Spinal Surgery
NCT03921385
Assessment of Physiological Parameters Measurements (Heart Rate, Respiratory Rate, and Oxygen Saturation) by Standard Acquisition System Compared Remote Photoplethysmography Imaging System l
NCT04660318
Design and Application of Airborne Visual Real-time Evaluation System for Air Medical Rescue
NCT03958682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: This study will utilize the 5G-based Remote Healthcare System (5G RHS) to connect four satellite Emergency Room (ER) teams with central experts to assess its effectiveness in critical cases. Data will be collected from July 2022 to June 2023 to address key research questions, including the circumstances prompting the use of 5G RHS, the extent of clinical improvement achieved, and the influence of central physician expertise, patient and physician locations, and calling time on clinical outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5G RHS group
For all patients receiving care through the 5G-based Remote Healthcare System (5G RHS) teleconsultation platform during the specified time period
The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System.
The 5G RHS group will receive audio-video conferencing and effective data management for decision-making via augmented reality platform. A total of 14 physicians from SRRSH will be participated in the study, offering remote consultations and instant guidance to the physician.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The 5G RHS group receiving audio-video conferencing and effective data management for decision-making via augmented reality platform RealHealthcare System.
The 5G RHS group will receive audio-video conferencing and effective data management for decision-making via augmented reality platform. A total of 14 physicians from SRRSH will be participated in the study, offering remote consultations and instant guidance to the physician.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\) Patients with acute chest pain, stroke and trauma were diagnosed in the departments of emergency medicine of the relevant medical community, Branches of Run Run Shaw Hospital, Zhejiang University School of Medicine.
* 3\) Voluntarily participate in the study and sign the informed consent; If the subject does not have the ability to understand or sign the informed consent, his/her guardian will represent him/her in the informed process and agree to participate in the study; If illiterate, his/her will need a witness to witness the knowledge process and his/her will decide to participate in the study.
Exclusion Criteria
* 2\) Minors.
* 3\) Pregnant women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sir Run Run Shaw Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yucai Hong
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yecheng Jin, M.D
Role: STUDY_DIRECTOR
Sir Run Run Shaw Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023YFC3603100
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ky20220304-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.